Form 8-K - Current report:
SEC Accession No. 0000200406-25-000110
Filing Date
2025-04-15
Accepted
2025-04-15 08:14:19
Documents
21
Period of Report
2025-04-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20250415.htm   iXBRL 8-K 45366
2 EX-99.1 a2025q1exhibit991.htm EX-99.1 111385
3 EX-99.2 a2025q1exhibit992.htm EX-99.2 611636
4 EX-99.3 a2025q1exhibit993.htm EX-99.3 5069
9 image_0.jpg GRAPHIC 244
10 image_1a.jpg GRAPHIC 339
11 jnjlogo.jpg GRAPHIC 2962
12 jnjlogoa.jpg GRAPHIC 2962
  Complete submission text file 0000200406-25-000110.txt   1054371

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20250415.xsd EX-101.SCH 4583
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20250415_def.xml EX-101.DEF 10568
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20250415_lab.xml EX-101.LAB 38371
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20250415_pre.xml EX-101.PRE 22234
23 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20250415_htm.xml XML 10683
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 25837644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)